These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 26436906)

  • 41. Comparison of biodistribution, dosimetry, and outcome from clinical trials of radionuclide-CC49 antibody therapy.
    Meredith R; Shen S; Macey D; Khazaeli MB; Carey D; Robert F; LoBuglio A
    Cancer Biother Radiopharm; 2003 Jun; 18(3):393-404. PubMed ID: 12954125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An optimization study for targeted alpha therapy: Ion behaviours and dose calculations within ICRU-compact bone tissue.
    Kara A
    Appl Radiat Isot; 2023 Jan; 191():110552. PubMed ID: 36370473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radioimmunotherapy of leukemia.
    Burke JM; Jurcic JG
    Adv Pharmacol; 2004; 51():185-208. PubMed ID: 15464910
    [No Abstract]   [Full Text] [Related]  

  • 44. High-linear energy transfer irradiation targeted to skeletal metastases by the alpha-emitter 223Ra: adjuvant or alternative to conventional modalities?
    Bruland ØS; Nilsson S; Fisher DR; Larsen RH
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6250s-6257s. PubMed ID: 17062709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Targeted Radioisotope Therapy-Current Status and Future Perspectives].
    Higashi T
    Gan To Kagaku Ryoho; 2018 Oct; 45(10):1391-1395. PubMed ID: 30382030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiotoxicity of bismuth-213 bound to membranes of monolayer and spheroid cultures of tumor cells.
    Kennel SJ; Stabin M; Roeske JC; Foote LJ; Lankford PK; Terzaghi-Howe M; Patterson H; Barkenbus J; Popp DM; Boll R; Mirzadeh S
    Radiat Res; 1999 Mar; 151(3):244-56. PubMed ID: 10073661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeted alpha therapy of prostate cancer.
    Allen BJ; Li Y; Rizvi SM; Russell PJ
    Methods Mol Med; 2003; 81():333-57. PubMed ID: 12725130
    [No Abstract]   [Full Text] [Related]  

  • 48. The advantage of antibody cocktails for targeted alpha therapy depends on specific activity.
    Pasternack JB; Domogauer JD; Khullar A; Akudugu JM; Howell RW
    J Nucl Med; 2014 Dec; 55(12):2012-9. PubMed ID: 25349219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Somatostatin-receptor-targeted alpha-emitting 213Bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells.
    Nayak TK; Norenberg JP; Anderson TL; Prossnitz ER; Stabin MG; Atcher RW
    Nucl Med Biol; 2007 Feb; 34(2):185-93. PubMed ID: 17307126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Manual on the proper use of sodium astatide ([
    Watabe T; Hosono M; Kinuya S; Yamada T; Yanagida S; Namba M; Nakamura Y
    Ann Nucl Med; 2021 Jul; 35(7):753-766. PubMed ID: 33978932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Theoretical Model for Predicting and Optimizing
    Ma W; Wang X; Liu W; Ma H; Su Y; Yang Y; Liu N; Wang Y; Yang G
    Radiat Res; 2019 May; 191(5):475-482. PubMed ID: 30830838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Envisaging an alpha therapy programme in the atomic energy establishments: the priorities and the nuances.
    Basu S; Banerjee S
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1244-1246. PubMed ID: 28364163
    [No Abstract]   [Full Text] [Related]  

  • 53. The Future of Radioligand Therapy: α, β, or Both?
    Haberkorn U; Giesel F; Morgenstern A; Kratochwil C
    J Nucl Med; 2017 Jul; 58(7):1017-1018. PubMed ID: 28408527
    [No Abstract]   [Full Text] [Related]  

  • 54. Letter from the Editors.
    Sathekge MM; Bouchelouche K
    Semin Nucl Med; 2020 Mar; 50(2):115-117. PubMed ID: 32172794
    [No Abstract]   [Full Text] [Related]  

  • 55. REGIST: right time to renovate?
    Burton A
    Eur J Cancer; 2007 Jul; 43(11):1642. PubMed ID: 17882765
    [No Abstract]   [Full Text] [Related]  

  • 56. ESMO 2017 Congress.
    Gourd K
    Lancet Oncol; 2017 Oct; 18(10):1302. PubMed ID: 28919084
    [No Abstract]   [Full Text] [Related]  

  • 57. The evolution of cancer care for children and adults.
    Simone JV; Lyons J
    J Clin Oncol; 1998 Sep; 16(9):2904-5. PubMed ID: 9738556
    [No Abstract]   [Full Text] [Related]  

  • 58. [Radioisotopes and cancer].
    DUFRESNE O
    Union Med Can; 1951 Oct; 80(10):1211-3. PubMed ID: 14893587
    [No Abstract]   [Full Text] [Related]  

  • 59. Approach toward molecular targeted therapy for cancer using microbial products.
    Imoto M
    J Antibiot (Tokyo); 2021 Oct; 74(10):601-602. PubMed ID: 34565796
    [No Abstract]   [Full Text] [Related]  

  • 60. Advances in targeted alpha therapy of cancer.
    Sathekge M; Morgenstern A
    Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1205-1206. PubMed ID: 38376807
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.